133 related articles for article (PubMed ID: 12779045)
1. Synthesis, characterization and mutagenicity of new cis-[Pt(2-substituted-benzimidazole)2Cl2] complexes.
Gümüş F; Demirci AB; Ozden T; Eroğlu H; Diril N
Pharmazie; 2003 May; 58(5):303-7. PubMed ID: 12779045
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxic activity on MCF-7 cell line and mutagenic activity of platinum(II) complexes with 2-substituted benzimidazole ligands.
Gümüş F; Algül O; Eren G; Eroğlu H; Diril N; Gür S; Ozkul A
Eur J Med Chem; 2003 May; 38(5):473-80. PubMed ID: 12767597
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and in vitro cytotoxic, mutagenic and antimicrobial activity of platinum(II) complexes with substituted benzimidazole ligands.
Gümüş F; Pamuk I; Ozden T; Yildiz S; Diril N; Oksüzoglu E; Gür S; Ozkul A
J Inorg Biochem; 2003 Mar; 94(3):255-62. PubMed ID: 12628705
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, spectroscopic, mutagenic, and cytotoxicity studies of some mixed-ligand platinum(II) complexes of 2,2'-bipyridine and amino acids.
Jain N; Mital R; Ray KS; Srivastava TS; Bhattacharya RK
J Inorg Biochem; 1987 Sep; 31(1):57-64. PubMed ID: 3320273
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro cytotoxicity of lipophilic platinum(II) complexes.
Kokotos G; Theodorou V; Constantinou-Kokotou V; Gibbons WA; Roussakis C
Bioorg Med Chem Lett; 1998 Jun; 8(12):1525-30. PubMed ID: 9873383
[TBL] [Abstract][Full Text] [Related]
7. Platinum(II), platinum(IV), and palladium (II) complexes of amino substituted phosphine oxides: synthesis, characterization, and antitumor activity.
Dodoff N; Varbanov S; Borisov G; Spassovska N
J Inorg Biochem; 1990 Jul; 39(3):201-8. PubMed ID: 2394997
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNA.
Vickery K; Bonin AM; Fenton RR; O'Mara S; Russell PJ; Webster LK; Hambley TW
J Med Chem; 1993 Nov; 36(23):3663-8. PubMed ID: 8246235
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and antitumor activity of 1,2-bis(diphenylphosphino) ethane platinum(II) and palladium(II) complexes.
Khokhar AR; Xu QY; Siddik ZH
J Inorg Biochem; 1990 Jun; 39(2):117-23. PubMed ID: 2380705
[TBL] [Abstract][Full Text] [Related]
11. Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline.
Romerosa A; Bergamini P; Bertolasi V; Canella A; Cattabriga M; Gavioli R; Mañas S; Mantovani N; Pellacani L
Inorg Chem; 2004 Feb; 43(3):905-13. PubMed ID: 14753810
[TBL] [Abstract][Full Text] [Related]
12. Platinum(IV) complexes with some derivatives of 5-methyl-5-(4-pyridyl) hydantoin. Synthesis, study and comparative pharmacological investigation.
Bakalova A; Buyukliev R; Ivanova Z; Momekov G; Ivanov D
Drug Res (Stuttg); 2013 Aug; 63(8):420-3. PubMed ID: 23677699
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
14. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular structure determination, and antitumor activity of platinum(II) and palladium(II) complexes of 2-substituted benzimidazole.
Mylonas S; Valavanidis A; Dimitropoulos K; Polissiou M; Tsiftsoglou AS; Vizirianakis IS
J Inorg Biochem; 1988 Dec; 34(4):265-75. PubMed ID: 3253411
[TBL] [Abstract][Full Text] [Related]
16. Platinum(II) complexes of 4-methoxy- and 4-chlorobenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect.
Dodoff N; Grancharov K; Spassovska N
J Inorg Biochem; 1995 Dec; 60(4):257-66. PubMed ID: 8530921
[TBL] [Abstract][Full Text] [Related]
17. Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.
Venitt S; Crofton-Sleigh C; Agbandje M; Jenkins TC; Neidle S
J Med Chem; 1998 Sep; 41(19):3748-52. PubMed ID: 9733500
[TBL] [Abstract][Full Text] [Related]
18. Bacterial mutation test on plafibride.
Richold M; Jones E
Arzneimittelforschung; 1981; 31(10a):1838-40. PubMed ID: 7032531
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and DNA binding studies of platinum(II) complexes with benzimidazole derivative ligands.
Tarı Ö; Gümüş F; Açık L; Aydın B
Bioorg Chem; 2017 Oct; 74():272-283. PubMed ID: 28881255
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.
Ang WH; Pilet S; Scopelliti R; Bussy F; Juillerat-Jeanneret L; Dyson PJ
J Med Chem; 2005 Dec; 48(25):8060-9. PubMed ID: 16335930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
